IL6 and COVID-19: In acute COVID-19, a significant increase in serum and CSF levels of IL-6 and other cytokines could be demonstrated, which was often associated with BCB dysfunction, partly remaining positive at high levels for weeks and, in the few patients with long-term data tested, even months [10].